Rubicon Organics is an International Cannabis Powerhouse in the Making
Robin Lefferts
June 26th, 2018
Exclusive, News, Top News
Organic. It’s a word many consumers love, driving them to pay upwards of 100% premiums for organic products. It’s a word pesticide companies loathe, impeding their profits and leading to bad press. It’s a standard to which the cannabis industry aspires, with The Green Organic Dutchman’s recent successful IPO as the latest example. With fully-built production facilities in British Columbia and in Washington State, and assets and operations in California, Rubicon Organics is a real, operations-based company that is well positioned for its public listing in Q3 this year.
Click here to see the company’s corporate presentation and get a going public alert.
What Rubicon Organics Has
One thing Rubicon has in spades is proven success in certified-organic production of cannabis under the MMPR and ACMPR, Health Canada’s past and current medical cannabis program. CEO Jesse McConnell co-founded Whistler Medical Marijuana Company, one of Canada’s original ten Licensed Producers and the first to be certified organic. Rubicon’s CSO wrote the Certified Organic Cannabis Standard (ISO 17065, FVOPA) in Canada and led Whistler through the organic certification process. The CSO has 15 years of experience in high tech greenhouse production of vegetables and 5 years of cannabis experience. The two have since combined forces to perfect organic cannabis production in greenhouses rather than the indoor facilities used by Whistler. Rubicon Organics is the culmination of that process. The company can reliably produce consistent premium organic cannabis at a cost of less than C$.50/gram once its facilities are through start-up phase.
Rubicon is currently wrapping up the retrofit of a 125,000 square foot greenhouse facility in the Delta, BC area and is in the final stages of the ACMPR licensing process. The company anticipates approval in the next few months, likely to coincide with going public. Rubicon plans to undertake further expansion of the BC production facility after the initial license, targeting production of about 67,000 kg/year by 2020.
However, as opposed to many prospective ACMPR licensees, Rubicon has existing operations and is actually currently selling products in other jurisdictions. Its brand, 1964 Supply Co.™ (the name is a nod to the year in which Dr. Raphael Mechoulam discovered the THC molecule) is currently produced, branded, and distributed throughout the state.
In Washington, Rubicon has completed a 40,000 sf purpose-built glass greenhouse with Phase 1 capacity of 4,400 kg/year and is able to expand to about 15,000 kg/year by 2020. The facility is being leased to a tenant operator.
Click here to see the company’s corporate presentation and get a going public alert.
Where Rubicon Organics is Going
The stage is set for Rubicon Organics in some of North America’s key markets. Canada, Washington, and California combined represent about 58% of the legal cannabis market in North America. In those three markets, the company looks to generate around $275 million in yearly revenue by 2020. That is a very appealing number, but Rubicon’s plans are actually much more ambitious.
The company sees global potential for its organic cannabis. By combining brands developed and molded in the trend-defining markets of California with the global recognition of “BC Bud” and the consumer demand for organic products, Rubicon looks to create a global brand house featuring premium products designed for both medical and recreational use.
Along that path and following the company’s public listing, Rubicon aims to implement an aggressive marketing program to solidify its brand presence in the US, with plans to introduce the 1964 Supply Co.™ brand to the Canadian market in early 2019. The company already has laid the groundwork for distribution into Germany as well, which currently comprises Europe’s largest medical cannabis market and offers insurance coverage for cannabis treatments.
In recognition of the recreational market and the industry trends toward consumer products derived from cannabis (like edibles, oils, beverages and cosmetics), the company has been building an impressive executive team with relevant backgrounds. Rubicon’s President, Tim Roberts, has an extensive consumer goods background and recently held senior executive positions with Red Bull and Diageo. VP of Sales and Marketing Jason Pak comes from executive sales positions with Anheuser-Busch and Heineken.
Click here to see the company’s corporate presentation and get a going public alert.
The Upshot
Rubicon Organics is laying the groundwork for North American and global success. With proprietary and certified organic grow operations, many years of cannabis experience, presence in key markets with a clear plan for expansion, existing brands, low cost high quality production… there are many reasons to think Rubicon Organics could be the next major player in the explosive growth of the legal cannabis industry.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Robin Lefferts
Robin Lefferts has been involved in the legal cannabis industry since 2012, sometimes as an active participant and always as an interested observer.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Chemesis International is a vertically integrated global leader in the cannabis industry, currently operating within Puerto Rico, and California.
MagicMed Industries intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
